Top Markets
#1 Black Phoenix Black Phoenix +829.12%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +32.51%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.20%
#4 Beam Beam +22.22%
#5 SAFEcoin SAFEcoin +20.72%
#6 YFSX YFSX +20.23%
#7 pipedog pipedog +20.01%
#8 Magma Finance Magma Finance +18.85%
#9 Bless Bless +16.87%
#10 THORChain THORChain +15.83%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rank in Stocks #5728
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Share Price
$29.86
Last synced: 2026-08-19
Market Cap
$2.48B
Change (1 day)
4.92%
Change (1 year)
502.82%
Country
TW
Trade Lin BioScience, Inc. (6696)

Category

Healthcare
Number of shares outstanding for Lin BioScience, Inc. (6696)
Number of shares outstanding as of August 2026: 0
According to Lin BioScience, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Lin BioScience, Inc. (6696) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH